Depo-SubQ Provera

Pharmacia & Upjohn Company LLC🇺🇸 United States

FDA Page

Effective Date: Dec 14, 2020
Approval ID: 390087a6-f3c3-4f0b-a930-79acf412f153
Products: 1 registered
Version: 17

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use DEPO-SUBQ PROVERA 104 safely and effectively. See full prescribing information for DEPO-SUBQ PROVERA 104. DEPO-SUBQ PROVERA 104 (medroxyprogesterone acetate) injectable suspension, for subcutaneous useInitial U.S. Approval: 1959

Quick Stats

Total Products1

Labelers2

Label Sections20

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.